Corvus Pharmaceuticals, Inc. CRVS
10.54 USD +0.81 (+8.32%)
At closeNov 6, 2026, 4:01 PM EST
10.54 0.00 0.00%
After hours · Nov 6, 4:01 PM ET
9.64 Day range 10.96
6.50 52-week range 25.52
- YTD
- +36.88%
- 1 year
- +34.78%
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -42.97M | -27.54M | -23.41M | -32.54M | -38.63M | |
| -15.28M | -62.29M | -27.03M | -41.31M | -43.24M | |
| -0.53 | -1.02 | -0.56 | -0.89 | -1.03 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 4.58M | 8.74M | 12.62M | 13.16M | 63.46M | |
| 71.12M | 68.91M | 45.55M | 68.24M | 109.45M | |
| 9.91M | 36.34M | 6.87M | 12.13M | 12.29M | |
| 937.00K | 1.12M | 1.37M | 2.60M | 3.65M | |
| 61.20M | 32.57M | 38.68M | 56.12M | 97.16M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -32.80M | -25.42M | -23.93M | -27.02M | -36.72M | |
| -7.80M | -27.48M | 15.54M | -23.28M | 21.56M | |
| 36.43M | 49.03M | 7.86M | 0 | 62.16M | |
| -174.00K | 5.00K | -34.00K | -247.00K | -5.00K | |
| -4.16M | -3.88M | -539.00K | -50.30M | 47.00M |